BAX
Price
$24.50
Change
-$0.06 (-0.24%)
Updated
Aug 26, 11:14 AM (EDT)
Capitalization
12.61B
65 days until earnings call
SYK
Price
$390.18
Change
-$0.70 (-0.18%)
Updated
Aug 26, 11:44 AM (EDT)
Capitalization
149.44B
65 days until earnings call
Interact to see
Advertisement

BAX vs SYK

Header iconBAX vs SYK Comparison
Open Charts BAX vs SYKBanner chart's image
Baxter International
Price$24.50
Change-$0.06 (-0.24%)
Volume$200
Capitalization12.61B
Stryker
Price$390.18
Change-$0.70 (-0.18%)
Volume$500
Capitalization149.44B
BAX vs SYK Comparison Chart in %
Loading...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAX vs. SYK commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a StrongBuy and SYK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 26, 2025
Stock price -- (BAX: $24.56 vs. SYK: $390.88)
Brand notoriety: BAX and SYK are both not notable
BAX represents the Pharmaceuticals: Other, while SYK is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BAX: 104% vs. SYK: 74%
Market capitalization -- BAX: $12.61B vs. SYK: $149.44B
BAX [@Pharmaceuticals: Other] is valued at $12.61B. SYK’s [@Medical/Nursing Services] market capitalization is $149.44B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.92B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $229.51B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.07B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAX’s FA Score shows that 2 FA rating(s) are green whileSYK’s FA Score has 2 green FA rating(s).

  • BAX’s FA Score: 2 green, 3 red.
  • SYK’s FA Score: 2 green, 3 red.
According to our system of comparison, SYK is a better buy in the long-term than BAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAX’s TA Score shows that 5 TA indicator(s) are bullish while SYK’s TA Score has 5 bullish TA indicator(s).

  • BAX’s TA Score: 5 bullish, 3 bearish.
  • SYK’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BAX is a better buy in the short-term than SYK.

Price Growth

BAX (@Pharmaceuticals: Other) experienced а +4.02% price change this week, while SYK (@Medical/Nursing Services) price change was +2.43% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.02%. For the same industry, the average monthly price growth was +1.74%, and the average quarterly price growth was +20.83%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +3.54%. For the same industry, the average monthly price growth was +2.83%, and the average quarterly price growth was +9.76%.

Reported Earning Dates

BAX is expected to report earnings on Oct 30, 2025.

SYK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+3.54% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYK($149B) has a higher market cap than BAX($12.6B). BAX has higher P/E ratio than SYK: BAX (87.85) vs SYK (52.21). SYK YTD gains are higher at: 9.046 vs. BAX (-14.894). SYK has higher annual earnings (EBITDA): 5.76B vs. BAX (1.04B). SYK has more cash in the bank: 2.46B vs. BAX (1.69B). BAX has less debt than SYK: BAX (9.73B) vs SYK (16.6B). SYK has higher revenues than BAX: SYK (23.8B) vs BAX (10.9B).
BAXSYKBAX / SYK
Capitalization12.6B149B8%
EBITDA1.04B5.76B18%
Gain YTD-14.8949.046-165%
P/E Ratio87.8552.21168%
Revenue10.9B23.8B46%
Total Cash1.69B2.46B68%
Total Debt9.73B16.6B59%
FUNDAMENTALS RATINGS
BAX vs SYK: Fundamental Ratings
BAX
SYK
OUTLOOK RATING
1..100
1464
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
71
Overvalued
PROFIT vs RISK RATING
1..100
10016
SMR RATING
1..100
9256
PRICE GROWTH RATING
1..100
6554
P/E GROWTH RATING
1..100
3121
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BAX's Valuation (17) in the Medical Specialties industry is somewhat better than the same rating for SYK (71). This means that BAX’s stock grew somewhat faster than SYK’s over the last 12 months.

SYK's Profit vs Risk Rating (16) in the Medical Specialties industry is significantly better than the same rating for BAX (100). This means that SYK’s stock grew significantly faster than BAX’s over the last 12 months.

SYK's SMR Rating (56) in the Medical Specialties industry is somewhat better than the same rating for BAX (92). This means that SYK’s stock grew somewhat faster than BAX’s over the last 12 months.

SYK's Price Growth Rating (54) in the Medical Specialties industry is in the same range as BAX (65). This means that SYK’s stock grew similarly to BAX’s over the last 12 months.

SYK's P/E Growth Rating (21) in the Medical Specialties industry is in the same range as BAX (31). This means that SYK’s stock grew similarly to BAX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BAXSYK
RSI
ODDS (%)
Bullish Trend 1 day ago
61%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
52%
Momentum
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
58%
MACD
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
54%
Bullish Trend 1 day ago
57%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
46%
Advances
ODDS (%)
Bullish Trend 1 day ago
51%
Bullish Trend 7 days ago
56%
Declines
ODDS (%)
Bearish Trend 6 days ago
61%
Bearish Trend 15 days ago
50%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
57%
Bearish Trend 1 day ago
64%
Aroon
ODDS (%)
Bearish Trend 1 day ago
55%
Bullish Trend 1 day ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SCDL39.832.15
+5.70%
ETRACS 2x Leveraged US Div Fctr TR ETN
PDT13.420.03
+0.22%
John Hancock Premium Dividend Fund
HEEM31.74-0.05
-0.17%
iShares Currency Hedged MSCI Em Mkts ETF
AUGU28.09-0.07
-0.24%
AllianzIM U.S. Equity Buffer15 UncAugETF
SPEM44.83-0.18
-0.40%
SPDR® Portfolio Emerging Markets ETF

BAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAX has been closely correlated with ALGN. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAX jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
+0.08%
ALGN - BAX
68%
Closely correlated
-3.08%
LUNG - BAX
53%
Loosely correlated
-1.18%
STE - BAX
51%
Loosely correlated
-1.35%
SYK - BAX
51%
Loosely correlated
-0.85%
SOLV - BAX
50%
Loosely correlated
-1.09%
More

SYK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYK has been loosely correlated with BSX. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if SYK jumps, then BSX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYK
1D Price
Change %
SYK100%
-0.85%
BSX - SYK
65%
Loosely correlated
-1.00%
ISRG - SYK
65%
Loosely correlated
-1.62%
A - SYK
56%
Loosely correlated
-2.04%
STE - SYK
55%
Loosely correlated
-1.35%
MDT - SYK
54%
Loosely correlated
-0.72%
More